Clinical Trial Update: Efficacy and Safety of Fixed Dose Combination GSP 301 Nasal Spray (NS) in the Treatment of Seasonal Allergic Rhinitis (SAR) [Phase 3]

View source ↗

Summary

Phase 3 trial results for fixed dose combination GSP 301 nasal spray in seasonal allergic rhinitis have been completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seasonal Allergic Rhinitis

Drugs mentioned

• GSP 301

Snippet

Sponsor: Glenmark Specialty S.A. | Conditions: Seasonal Allergic Rhinitis | Phase 3 | Status: COMPLETED | Results posted: 2018-08-15